Abstract
INTRODUCTION
Bone marrow stimulation (BMS) is a reparative pro cedure for osteochondral lesions of the talus (OLT) [1] . The aim of this arthroscopic procedure is to stimulate mesenchymal stem cells (MSCs) to promote fibrous cartilage tissue by breaching the subchondral bone plate (SBP) using an awl or wire [1] . Several investigators have demonstrated good to excellent clinical outcomes in around 85% of patients, treated with BMS for OLT, for the short to medium term [2] . The main prognostic factor in the treatment of OLT has been regarded as the lesion size [1, 3, 4] . The maximum size for BMS treatment is generally accepted as less than 15 mm in diameter or 150 mm 2 in area. Chuckpaiwong et al [4] found that smaller than 15 mm in diameter was the critical cutoff value to obtain a successful outcome following BMS. Choi et al [5] concluded that 150 mm 2 is the critical defect area beyond clinical outcomes following BMS for OLT decreased significantly. However, a recent systematic review by Ramponi et al [6] showed the critical lesion size to be 107.4 mm 2 in area and/or 10.2 mm in diameter, for BMS. Containment of the lesion has also been demonstrated as a universally accepted prognostic factor for good clinical outcomes following BMS for OLT [3, 7] . Recently, level of evidence (LOE) and methodological quality of evidence (MQOE) have been used to assess relative value of outcomes reported in the clinical studies [811] . Despite the widespread clinical use of lesion size as a cutoff value for BMS in OLT, there has been no comprehensive assessment of LOE and QOE for clinical studies accompanying both the lesion size and clinical outcomes. The same can be said for the presence or absence of containment of OLT.
The purpose of this systematic review was to clarify the LOE and MQOE of for the published literature in vestigating clinical outcome following BMS for OLT, with special emphasis on studies investigating lesion size and containment as predictors.
MATERIALS AND METHODS

Search strategy
A systematic literature search of the PubMed/MEDLINE and EMBASE databases was performed in March 2015 in accordance with the Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) guide lines [12] . Each database was searched using the following key words, (microfracture OR microdrilling OR drilling OR drill OR bone marrow stimulation OR marrow stimulation OR BMS OR abrasion chondroplasty OR arthroscopy OR arthroscopic) AND (talus OR talar OR ankle) AND (cartilage OR osteochondritis dissecans OR chondral OR osteochondral OR transchondral OR osteochondral lesion OR OCL OR OCD).
Titles and abstracts were screened using specific inclusion and exclusion criteria. Full texts of potentially relevant studies were then reviewed. Citations and references of all articles and relevant studies were man ually assessed. Studies were searched and independently assessed by two independent reviewers. Differences between reviewers were discussed together and resolved by consensus or if a persistent disagreement occurred, a senior author was consulted.
Inclusion and exclusion criteria
Currently BMS is defined as microfracture, drilling, or abrasion. The inclusion criteria of the current systematic review was the following: (1) therapeutic clinical studies evaluating both lesion size of OLT and outcomes in patients who underwent BMS; (2) all patients included had more than a 24 mo follow up; (3) published in a peerreview journal; (4) published in English; and (5) full text of studies available. Exclusion criteria was the following: (1) cadaveric studies; (2) animal studies; (3) case reports; (4) review articles; (5) technique articles; (6) articles with unseparated results if more than one technique is described; (7) inadequately surgical technique description; (8) use of scaffolds; and (9) errors in reported data.
Data extraction and analysis
Two independent reviewers performed data extraction for each study. If any discrepancy existed, the senior author evaluated all available data and a consensus was reached. Studies that included more than one surgical procedure or a subgroup of patients with different follow up times were included in the data for analysis [13, 14] . The primary outcome of current study was LOE and MQOE of included studies. LOE of each study was graded based on the previously published criteria [15] . MQOE was assessed using the Modified Coleman Methodology Score (MCMS) (Table 1) [6] . This score consists of 2 parts, Part A (primarily evaluates baseline study characteristics; 060) and Part B (primarily evaluates outcome criteria and recruitment rates; 040). According to Jakobsen's CMS, the score of excellent studies are between 85 to 100 points; good studies 70 to 84 points, fair studies 55 to 69 points and poor studies scored under 55 points [9] .
Statistical analysis
The statistical analysis was performed using a com mercially available contemporary statistical software package (SAS 9.3; SAS Institute, Cary, NC, United States). In CMMS, all obtained scores were adjusted to percentage (each score/total score), the adjusted scores of CMMS were compared between Part A and Part B to determine statistical significance. As a ShapiroWilk's W test showed nonnormal distributed data, the Mann Whitney U test was performed for this. Additionally, the adjusted score of each parameter were compared to investigate any difference using the KruskalWallis test and SteelDwass test for data obtained without standard Gaussian distribution. A Pvalue < 0.05 was considered statistically significant.
RESULTS
The flow diagram is shown in Figure 1 . After full texts articles were assessed based on the inclusion/exclusion criteria. There were 22 clinical studies included in the current systematic review [35, 7, 13, 1632] .
Demographics
Summary of the demographic data was shown in Table 2 : 1.879 ankles were identified (931 males; 545 females) [35, 7, 13, 1632] . The mean lesion area was 111.9 mm 2 and the mean diameter was 9.5 mm. The mean followup was 48.5 (range 24146) mo.
LOE
Overall, 95.5% of the studies included were level Ⅳ [4, 7, 17, 18, 20, 22, 2529, 31] or level Ⅲ [3, 5, 16, 19, 21, 23, 30, 32] . No level Ⅰ studies were included in the current review. Gobbi et al [13] , was described as LOE Ⅰ in the published journal, however, this study was reassigned as LOE Ⅱ (prospective cohort study). Table 2 shows information about LOE (Table 2) .
MQOE
The mean MCMS was 57.5 ± 10.2 out of 100 points (range 3889) ( MCMS of Part A were significantly higher than that of Part B (P < 0.05). In the part A, the adjusted MCMS of "Type of study" were significantly lower among all the parameters (P < 0.05). With regard to Part B, "Outcome criteria" had significantly higher scores compared with the others (P < 0.05). Of the 22 included studies, 14 studies (63.6%) were of fair quality [35, 13, 19, 20, 2325, 27, 28, 3032] , 7 (31.7%) of poor quality [7, 1618, 22, 26, 28] and only 1 (4.5%) study [21] .
DISCUSSION
The aim of this systematic review is to clarify LOE and MQOE of published literature on BMS for OLT. Twentytwo studies with 1.879 patients were included, however, no level I study was identified in the study cohort. The result demonstrated that most of the studies reported the lesion sizes and the containment of the lesion were graded as low LOE. The quality of evidence in these studies demonstrated an average MCMS of 57.5 out of 100 points and only 4.5% of included studies were graded as excellent, which suggests that the methodological quality of the included studies was weak. In addition, scores of Part B (primarily evaluates outcome criteria and recruitment rates) was marked significantly lower than Part A (primarily evaluates baseline study characteristics. This systematic review has revealed that studies with low LOE and weak MQOE have supported this paradigm despite lesion size and the containment of the lesion being a common criteria value for the indication for BMS in treating OLT. Lesion size and the containment of the lesion are accepted prognostic factors to use when making a decision in operative treatment for OLT [3, 7] . In general, lesion size with less than 15 mm in diameter or less than 150 mm 2 are applied for BMS. It is also well known that a noncontained OLT have a worse outcome than a contained OLT [7] . However, this systematic review has revealed that most of these studies were of low LOE, and recently, several investigators evaluated the trend of LOE of published clinical studies in sportrelated journals [33] . Unfortunately greater than 80% of studies in foot and ankle surgery remain to have low LOE despite increasing numbers of the LOE I and LOE II studies in the clinical sports medicine literature [9, 10, 33] . High-level clinical evidence can fundamentally provide adequate treatment for patients based on the principles of evidencebased medicine [34] . Additionally, Moher et al [35] described that nonblinded clinical studies without allocation concealment tended to describe an overestimated treatment effect than blinded clinical studies and well designed blinded case control studies are required to establish prognostic factors in BMS for OLT. The current systematic study revealed that the MQOE of the included 22 studies have been weak (Table  3 ) [9] . Of those clinical studies "Procedure for assessing outcomes" and "Description of subject selection process" in Part B (primarily evaluates outcome criteria and recruitment rates) were significantly low. These findings are consistent with the outcomes found by a recent systematic review that analyzed the outcome data following microfracture for OLT in 24 clinical studies [36] . The authors found that approximately half of included studies did not have a patient history or patient reported outcome data, despite the presence of well described general demographics and study design. Additionally, clinical variables (48%) and imaging data (39%) has been the least reported in these studies. Poor methodological quality of the clinical study decreases the reliability of study's outcomes [37] . However, caution should be taken when interrupting the outcomes of methodological quality. The methodological deficiencies have been reported using Coleman Methodological Score for tendinopathy [8, 38] , knee cartilage lesion [9] , fracture [39] , ligament injury [4042] and OLT [43] . However, to our knowledge, the validity and reliability of this score for OLT is unknown. Nevertheless, we believe the outcome of the current study is important because the modification for MCMS in the current study could improve the validity and reliability of this score for OLT. Several limitations of the current study exist mainly due to the inclusion criteria. Studies published in database other than MEDLINE and EMBASE were not included. Clinical studies not written in English were not evaluated. Nevertheless, this study does demonstrate important findings of that the LOE and QOE of published literature, on using BMS for OLT, are insufficient to produce any solid conclusion. A further limitation was that the current study focused only on the available clinical studies. As a result, the outcomes have ad dressed very little of the underlying mechanisms and intrinsic limitations of BMS for OLT. Currently, underlying biological aspects of cartilage regeneration has been well discussed due to low intrinsic activity of reparative cartilaginous tissue following BMS and potential ability of biological factors, although a recent systematic review has suggested a comprehensive assessment of the evidence behind the translation of basic science to the clinical practice [44, 45] . Thus, the usefulness of the outcomes from the current study depends essentially on critical appraisal of the literature on the clinical application.
In conclusion, lesion size and the containment of OLT is a commonly used prognostic parameter in the treatment of osteochondral lesion of the talus However, this systematic review has revealed that low levels of evidence and weak quality of evidence in clinical studies need to be improved before this paradigm can be fully supported.
COMMENTS
Background
Lesion sizes and containment are commonly used in the orthopaedic community to predict the clinical outcomes of bone marrow stimulation for osteochondral lesion of talus.
Research frontiers
The widespread use of lesion size and containment as prognostic indicators prompts a much-needed comprehensive assessment of the studies supporting this data.
Innovations and breakthroughs
The evidence supporting the use of lesion size and containment as prognostic indicators of bone marrow stimulation (BMS) for osteochondral lesion of the talus (OLTs) have been revealed in this study to be of low level of evidence (LOE) and of weak methodological quality of evidence. Future studies with more robust study designs are warranted should the current paradigm ever need to be fully supported. 
